JNap (@jnap5c) 's Twitter Profile
JNap

@jnap5c

Think big, think positive, never show any sign of weakness. Always go for the throat. Buy low, sell high. Fear? That's the other guy's problem.

ID: 84312619

linkhttp://www.Bio5C.com/disclaim calendar_today22-10-2009 12:29:31

1,1K Tweet

13,13K Followers

236 Following

U.S. FDA (@us_fda) 's Twitter Profile Photo

In our latest FDA Direct conversation, we dive into recent policy changes: • Updates on the Commissioner’s National Priority Voucher program • Review of certain clinical trials involving foreign labs • Dr. Marty Makary insights from the BIO Conference

Secretary Kennedy (@seckennedy) 's Twitter Profile Photo

The mission to Make America Healthy Again (MAHA) includes MABA — Make American Biotech Accelerate. President Trump showed in his first term what happens when you unlock American science — breakthroughs happen fast. Now, we’re going to do it again. We know the power of U.S.

Scott Jennings (@scottjenningsky) 's Twitter Profile Photo

Does anyone remember Justice Kagan being against nationwide injunctions when we had a DEMOCRAT President? Pepperidge Farms remembers.

JNap (@jnap5c) 's Twitter Profile Photo

With the worst-case financial crisis looking averted, $SRPT should absolutely buy back (open-market) its 2027 debt. Buy as much as possible. Last quote was 60¢ on the dollar.

JNap (@jnap5c) 's Twitter Profile Photo

So... $MDGL spent $120M (+$2B in biobucks) for a preclinical Chinese Orfo knock-off. $GPCR has a Chinese Orfo knock-off at only $177M EV ($969M MCap - $792M in June 2025 Cash), with P2b data in Dec 2025. What say you?

Seedy19tron (@seedy19tron) 's Twitter Profile Photo

long idea 🚨 - will add in size tomorrow. $sndx ! This launch is sooo solid! AML launch comp table below (excuse my presentation skills) 2 full quarters in, better than any other AML launch. Also note it’s the ONLY (and 1st) Menin Inhibitor for the treatment of relapsed or

long idea 🚨 - will add in size tomorrow. $sndx ! This launch is sooo solid! 
AML launch comp table below (excuse my presentation skills) 2 full quarters in, better than any other AML launch. 
Also note it’s the ONLY (and 1st) Menin Inhibitor for the treatment of relapsed or
JNap (@jnap5c) 's Twitter Profile Photo

$EYPT LUGANO topline data Mid 2026 LUCIA topline data Q3 2026 Looks like EYPT will beat OCUL to NDA by 6-9 months.